Institutional shares held 142 Million
18.1K calls
200 puts
Total value of holdings $86.6M
$11K calls
$0 puts
Market Cap $154M
247,824,992 Shares Out.
Institutional ownership 57.27%
# of Institutions 121


Latest Institutional Activity in LYEL

Top Purchases

Q3 2024
Morgan Stanley Shares Held: 1.73M ($1.07M)
Q3 2024
Hrt Financial LP Shares Held: 569K ($353K)
Q3 2024
Goldman Sachs Group Inc Shares Held: 832K ($516K)
Q3 2024
Gsa Capital Partners LLP Shares Held: 355K ($220K)
Q3 2024
Balyasny Asset Management LLC Shares Held: 1.2M ($742K)

Top Sells

Q3 2024
Vanguard Group Inc Shares Held: 10.1M ($6.24M)
Q3 2024
Price T Rowe Associates Inc Shares Held: 7.35M ($4.56M)
Q3 2024
Baillie Gifford & CO Shares Held: 142K ($88K)
Q3 2024
Orbimed Advisors LLC Shares Held: 6.09M ($3.77M)
Q3 2024
Wu Xi App Tec Co., Ltd. Shares Held: 7.39M ($4.58M)

About LYEL

Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate for the treatment of non-small cell lung cancer and triple negative breast cancers; LYL845, that targets multiple solid tumors; and NY-ESO-1 for synovial sarcoma and other solid tumor indications. The company entered into research and development collaboration and license agreement with GlaxoSmithKline for NY-ESO-1 program. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.


Insider Transactions at LYEL

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
370K Shares
From 5 Insiders
Grant, award, or other acquisition 370K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on LYEL

Follow Lyell Immunopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LYEL shares.

Notify only if

Insider Trading

Get notified when an Lyell Immunopharma, Inc. insider buys or sells LYEL shares.

Notify only if

News

Receive news related to Lyell Immunopharma, Inc.

Track Activities on LYEL